

Naxpar Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 122.92 Cr
- Satisfied Charges ₹ 17.29 Cr
- Revenue Growth 2.48%
- Profit Growth -3.74%
- Ebitda -1.14%
- Net Worth 16.21%
- Total Assets -3.09%
About Naxpar Pharma
Naxpar Pharma Private Limited (NPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 February 2004 and has a history of 21 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Parav Biopharm Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹122.92 Cr. The company has closed loans amounting to ₹17.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mihir Shah, Baiju Shah, Prakash Shah, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U52310MH2004PTC144449
- Company No.
144449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2004
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Naxpar Pharma?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mihir Shah ![]() | Whole-Time Director | 10-Feb-2004 | Current |
Baiju Shah ![]() | Whole-Time Director | 10-Feb-2004 | Current |
Prakash Shah ![]() | Whole-Time Director | 10-Feb-2004 | Current |
Harish Panpalia ![]() | Director | 11-Aug-2023 | Current |
Yogesh Varia ![]() | Director | 28-May-2021 | Current |
Financial Performance of Naxpar Pharma.
Naxpar Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.48% increase. The company also saw a slight decrease in profitability, with a 3.74% decrease in profit. The company's net worth Soared by an impressive increase of 16.21%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Naxpar Pharma?
In 2023, Naxpar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Parnax Lab Limited
Mihir Shah, Harish Panpalia and 1 more are mutual person
- Novomed Pharma Pvt. Ltd
Mihir Shah is a mutual person
Charges (Loans)
₹122.92 Cr
₹17.29 Cr
Charges Breakdown by Lending Institutions
- Others : 83.52 Cr
- Apna Sahakari Bank Ltd : 22.95 Cr
- Hdfc Bank Limited : 15.45 Cr
- Apna Sahakari Bank Limited : 1.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Dec 2023 | Hdfc Bank Limited | ₹14.16 Cr | Open |
25 Jul 2023 | Hdfc Bank Limited | ₹0.98 M | Open |
24 Dec 2021 | Others | ₹4.00 Cr | Open |
29 Oct 2021 | Hdfc Bank Limited | ₹7.89 M | Open |
31 Aug 2021 | Hdfc Bank Limited | ₹2.25 M | Open |
How Many Employees Work at Naxpar Pharma?
Naxpar Pharma has a workforce of 448 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Naxpar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naxpar Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Naxpar Pharma
Recent activity within the organization
- Annual General Meeting
Naxpar Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
- Balance Sheet
Naxpar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge with Others of Rs. 23.77 Cr registered on 30 Jan 2021 with Charge ID 100417613 was modified on 30 Mar 2024.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.16 Cr with Charge ID 100835802 was registered on 13 Dec 2023.
- Director Appointment
Harish Sunderlal Panpalia was appointed as a Director was appointed as a Director on 11 Aug 2023 & has been associated with this company since 1 year 8 months .
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100812836 was registered on 25 Jul 2023.
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Naxpar Pharma Private Limited?
Naxpar Pharma Private Limited was incorporated on 10 Feb 2004.
What is authorized share capital and paid-up capital of Naxpar Pharma Private Limited?
The authorized share capital of Naxpar Pharma Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 5.00 Cr.
Who are the current board members & directors of Naxpar Pharma Private Limited?
Currently 5 directors are associated with Naxpar Pharma Private Limited.
- Mihir Prakash Shah
- Baiju Mahasukhlal Shah
- Prakash Mahasukhlal Shah
- Harish Sunderlal Panpalia
- Yogesh Kantilal Varia
What is the registered address of Naxpar Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Naxpar Pharma Private Limited is 104-107Bldg No 8 Jogani Ind Complex Chunabhatti India, Mumbai, Maharashtra, 400022.
What is the corporate identification number (CIN) and company number of Naxpar Pharma Private Limited?
The corporate identification number (CIN) of Naxpar Pharma Private Limited is U52310MH2004PTC144449 and the company number is 144449 as per Ministry of Corporate Affairs (MCA).
What is the official website of Naxpar Pharma Private Limited?
The Official website of Naxpar Pharma Private Limited is https://www.naxparlab.com
What has been the recent revenue trend for Naxpar Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Naxpar Pharma Private Limited has risen by 2.48%.
How many employees does Naxpar Pharma Private Limited currently have?
As Per 2023 financial reports, 448 employees are currently employed by Naxpar Pharma Private Limited.
What change has been observed in the net worth of Naxpar Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Naxpar Pharma Private Limited has experienced an upsurge of 16.21%.
What are the total open charges for Naxpar Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Naxpar Pharma Private Limited amount to ₹ 122.92 Cr.
When was the last Balance Sheet of Naxpar Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Naxpar Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
VD
Vinayak DesaiDirectorMJ
Manharbhai JhavariDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India